查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650991

全球生物處理容器市場

Bioprocess Containers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 271 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生物處理容器市場規模將達到 343 億美元

2024 年全球生物處理容器市場規模估計為 95 億美元，預計到 2030 年將達到 343 億美元，2024 年至 2030 年的複合年成長率為 23.7%。報告中分析的細分市場之一，2D 生物處理容器，預計到分析期結束時複合年成長率為 27.1%，達到 223 億美元。在分析期內，3D 生物處理容器部分預計將以 19.0% 的複合年成長率成長。

美國市場預計將達到 28 億美元，中國市場複合年成長率將達到 22.6%

預計 2024 年美國生物加工容器市場價值將達到 28 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 51 億美元，2024-2030 年分析期間的複合年成長率為 22.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 21.5% 和 19.4%。在歐洲，預計德國的複合年成長率約為 15.6%。

全球生物加工容器市場-主要趨勢與促進因素摘要

生物加工容器如何形塑生物製造格局？

生物處理容器已成為生物製造領域的關鍵組成部分，徹底改變了生物材料的處理、儲存和加工方式。這些容器通常由先進的聚合物製成，專門設計用於安全有效地管理藥品、疫苗和生技藥品生產過程中生物加工的複雜需求。與傳統的不銹鋼系統不同，生物程序容器提供了靈活的一次性替代方案，大大降低了交叉污染的風險並簡化了您的製造作業。這在敏感生物製藥的製造中尤其重要，因為保持無菌和確保產品完整性至關重要。生物處理容器的採用也支持了模組化、可擴展的生物製造設施日益成長的趨勢，從而提高了製造過程的靈活性和效率。隨著對生技藥品和個人化醫療的需求不斷成長，生物處理容器對於滿足現代生物製造需求變得越來越重要。

生物處理容器對您的產業影響最大的是什麼？

生物處理容器對生物製造業的幾個關鍵領域產生重大影響。在製藥業，它們廣泛用於生產單株抗體、疫苗和其他生技藥品，並且由於是一次性使用，因此無需在批次之間進行清洗或滅菌，從而簡化了製造過程。這不僅減少了停機時間，還提高了整體生產效率並降低了污染風險。生物技術產業還在細胞和基因療法的開發和生產中使用生物程序容器，其中保持生物材料的無菌性和品質至關重要。此外，生物處理容器可用於試驗和商業規模的生物製藥生產，提供可輕鬆適應各種生產量的可擴展解決方案。生物製程容器也被受託製造廠商(CMO) 使用，提供滿足多個客戶的不同生產需求所需的靈活性和成本效益。因此，生物處理容器在最佳化生物製造過程和支持高品質生物製藥的生產方面發揮著至關重要的作用。

為什麼生物處理容器在生物製造上越來越受歡迎？

生物製程容器在生物製造領域的日益普及與產業向更靈活、更有效率和可擴展的生產方法的轉變相輔相成。使用生物處理容器的主要原因之一是降低污染風險，這是生物製藥生產的關鍵因素。由於是一次性使用，因此無需清洗或消毒，從而節省了時間並降低了營運成本，同時也最大限度地降低了批次之間交叉污染的風險。這對於生產多種產品或處理高度敏感生物材料的設施尤其重要。此外，生物處理容器提高了生產的靈活性，使製造商能夠快速回應需求和生產要求的變化，而無需對其基礎設施進行重大更改。此外，生物處理容器的模組化支持了製造設施向更小、更靈活的方向發展的趨勢，這些設施可以根據需要輕鬆擴大或縮小。此外，一次性系統更容易處理，對環境的影響更小，使得生物處理容器在日益增加的監管和永續性壓力下成為一個有吸引力的選擇。隨著生物製造業的不斷發展，生物處理容器在實現更有效率、更具適應性和永續的生產方法方面發揮關鍵作用。

哪些因素推動了生物處理容器市場的成長？

生物處理容器市場的成長受到幾個關鍵因素的推動。主要促進因素是對單株抗體、疫苗、細胞和基因療法等生技藥品的需求不斷成長，這些產品需要高度控制和無菌的製造環境。生物處理容器提供靈活、經濟高效的解決方案，可降低污染風險，同時滿足生技藥品製造的嚴格要求。生物製藥製造中一次性技術的趨勢也是關鍵因素。此外，受託製造廠商(CMO) 的擴張以及對適應性、擴充性製造解決方案的需求也促進了市場的成長。生物處理容器使 CMO 能夠有效率地管理不同客戶的多種產品的生產。此外，生物處理技術的進步，例如開發更耐用、更堅固的容器材料，正在提高生物處理容器的性能和可靠性，進一步促進其應用。生物製造領域對永續性的日益關注，尤其是減少水和能源消耗，也推動了生物處理容器市場的成長，因為生物處理容器符合產業的永續性目標。這些因素結合在一起，使得生物處理容器對於未來的生物製造至關重要。

部分

類型（2D 生物製程容器、3D 生物製程容器、其他類型）、應用（上游工程、下游、製程開發）、最終用途（製藥和生物製藥公司、CRO 和 CMO、學術和研究機構）

受訪企業範例（共38家）

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP10730

Global Bioprocess Containers Market to Reach US$34.3 Billion by 2030

The global market for Bioprocess Containers estimated at US$9.5 Billion in the year 2024, is expected to reach US$34.3 Billion by 2030, growing at a CAGR of 23.7% over the analysis period 2024-2030. 2D Bioprocess Containers, one of the segments analyzed in the report, is expected to record a 27.1% CAGR and reach US$22.3 Billion by the end of the analysis period. Growth in the 3D Bioprocess Containers segment is estimated at 19.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 22.6% CAGR

The Bioprocess Containers market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2030 trailing a CAGR of 22.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.

Global Bioprocess Containers Market - Key Trends and Drivers Summarized

How Are Bioprocess Containers Shaping the Landscape of Biomanufacturing?

Bioprocess containers have emerged as a critical component in the field of biomanufacturing, revolutionizing how biological materials are handled, stored, and processed. These containers, typically made from advanced polymers, are designed to safely and efficiently manage the complex needs of bioprocessing, particularly in the production of pharmaceuticals, vaccines, and biologics. Unlike traditional stainless steel systems, bioprocess containers offer a flexible, single-use alternative that significantly reduces the risk of cross-contamination and streamlines the production process. This is especially important in the production of sensitive biological products, where maintaining sterility and ensuring product integrity are paramount. The adoption of bioprocess containers also supports the growing trend towards modular and scalable biomanufacturing facilities, allowing for greater flexibility and efficiency in the production process. As the demand for biologics and personalized medicine continues to rise, bioprocess containers are becoming increasingly essential in meeting the needs of modern biomanufacturing.

Where Are Bioprocess Containers Making the Most Impact in the Industry?

Bioprocess containers are making a substantial impact across several key areas within the biomanufacturing industry. In the pharmaceutical sector, they are used extensively for the production of monoclonal antibodies, vaccines, and other biologics, where their single-use nature simplifies the production process by eliminating the need for cleaning and sterilization between batches. This not only reduces downtime but also enhances overall production efficiency and reduces the risk of contamination. The biotechnology industry is also leveraging bioprocess containers in the development and production of cell and gene therapies, where maintaining the sterility and quality of biological materials is critical. Additionally, bioprocess containers are used in the production of biopharmaceuticals at both the pilot and commercial scales, providing a scalable solution that can easily be adapted to different production volumes. The use of bioprocess containers in contract manufacturing organizations (CMOs) is another area of impact, where they offer the flexibility and cost-effectiveness needed to meet the diverse production demands of multiple clients. Across these applications, bioprocess containers are proving to be invaluable in optimizing the biomanufacturing process and supporting the production of high-quality biological products.

Why Are Bioprocess Containers Gaining Popularity in Biomanufacturing?

The growing popularity of bioprocess containers in biomanufacturing is closely linked to the industry's shift towards more flexible, efficient, and scalable production methods. One of the primary reasons for their adoption is the ability of bioprocess containers to reduce the risk of contamination, a critical factor in the production of biological products. Their single-use nature eliminates the need for cleaning and sterilization, which not only saves time and reduces operational costs but also minimizes the risk of cross-contamination between batches. This is particularly important in facilities that produce multiple products or work with highly sensitive biological materials. Moreover, bioprocess containers offer greater flexibility in production, allowing manufacturers to quickly adapt to changes in demand or production requirements without the need for significant infrastructure changes. The modularity of bioprocess containers also supports the trend towards smaller, more agile manufacturing facilities that can be easily scaled up or down as needed. Additionally, the ease of disposal and reduced environmental impact associated with single-use systems make bioprocess containers an attractive option in the context of increasing regulatory and sustainability pressures. As the biomanufacturing industry continues to evolve, bioprocess containers are playing a key role in enabling more efficient, adaptable, and sustainable production practices.

What Factors Are Driving the Growth of the Bioprocess Containers Market?

The growth in the bioprocess containers market is driven by several key factors. A major driver is the rising demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, which require highly controlled and sterile manufacturing environments. Bioprocess containers offer a flexible and cost-effective solution that meets the stringent requirements of biologic production while reducing the risk of contamination. The trend towards single-use technologies in biomanufacturing is another significant factor, as these systems provide greater flexibility, reduce capital expenditures, and simplify regulatory compliance. The expansion of contract manufacturing organizations (CMOs) and their need for adaptable and scalable production solutions is also contributing to the market growth, as bioprocess containers allow CMOs to efficiently manage the production of multiple products for different clients. Additionally, ongoing advancements in bioprocessing technology, including the development of more durable and robust container materials, are enhancing the performance and reliability of bioprocess containers, further driving their adoption. The increasing focus on sustainability in biomanufacturing, with an emphasis on reducing water and energy consumption, is also supporting the growth of the bioprocess containers market, as these systems align with the industry's sustainability goals. Together, these factors are propelling the market forward, making bioprocess containers an integral part of the future of biomanufacturing.

SCOPE OF STUDY:

The report analyzes the Bioprocess Containers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (2D Bioprocess Containers, 3D Bioprocess Containers, Other Types); Application (Upstream Processes, Downstream Processes, Process Development); End-Use (Pharma & Biopharma Companies, CROs & CMOs, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bioprocess Containers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Biopharmaceutical Production Propels Growth of Bioprocess Containers
    • Single-Use Technologies Spur Demand for Disposable Bioprocess Containers
    • Here's the Story: How Personalized Medicine Expands the Addressable Market for Bioprocess Containers
    • Rising Demand for Flexible Manufacturing Accelerates Adoption of Bioprocess Containers
    • Innovations in Sterility and Contamination Control Drive Growth in High-Performance Bioprocess Containers
    • Advances in Material Science Expand Opportunities in Durable and Resilient Bioprocess Containers
    • Pharmaceutical Cold Chain Logistics Throws the Spotlight on Temperature-Controlled Bioprocess Containers
    • Growing Focus on Sustainability Generates Demand for Eco-friendly Bioprocess Containers
    • Increased Outsourcing in Biomanufacturing Fuels Demand for Bioprocess Containers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Upstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Upstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Downstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Downstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Process Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Process Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for 2D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for 2D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for 3D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for 3D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for CROs & CMOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for CROs & CMOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Bioprocess Containers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • JAPAN
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CHINA
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • EUROPE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • GERMANY
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030

IV. COMPETITION